Samsung Catalyst Fund Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 8
- Investments
- 89
- Portfolio
- 31
- Exits
- 24
Samsung Catalyst Fund General Information
Description
Founded in 2013, Samsung Catalyst is a corporate venture capital arm of Samsung Electronics headquartered in Menlo Park, California. The firm prefers to invest in the automotive, artificial intelligence, cloud and data infrastructure, smart factory and robotics, autonomous systems, and digital health sectors. The firm has additional offices in Berlin, New York, Seoul, Tel Aviv, and Paris.
Contact Information
Website
www.samsungcatalyst.com
Year Founded
2013
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 3655 North 1st Street
- San Jose, CA 95134
- United States
+1 (650) 000-0000
Samsung Catalyst Fund Investments (89)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ada Health | 10-Feb-2022 | Later Stage VC | 00000 | Enterprise Systems (Healthcare) | Generating Revenue | |
| 0000000 | 01-Dec-2021 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | 0000000 00000000 |
| 0000000 00 | 08-Nov-2021 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | |
| 0000000 0000000000 | 26-Oct-2021 | 00000 00000 | 0000 | Application Specific Semiconductors | Generating Revenue | |
| 000000 | 24-Jun-2021 | 00000 00000 | Application Software | Generating Revenue | ||
| 00000000000 | 19-Mar-2021 | 0000 00000 | 00.00 | Fiberoptic Equipment | Generating Revenue | 0000000 00000 |
| 000000 000000 | 14-Dec-2020 | 00000 00000 | 0000 | Other Hardware | Generating Revenue | 00000 0000 |
| 00000 000000 | 01-Dec-2020 | 00000 00000 | 0000 | Other Services (B2C Non-Financial) | Generating Revenue | |
| Genome Medical | 23-Jul-2020 | Early Stage VC | 0000 | Clinics/Outpatient Services | Generating Revenue | 0000000 00 00.0 |
| Preventice Solutions | 15-Jul-2020 | Later Stage VC | 00000 | Diagnostic Equipment | Profitable |
Samsung Catalyst Fund Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Keyssa | 08-Dec-2021 | Merger/Acquisition | |
| 00000000 | 22-Oct-2021 | 0000000000 | |
| 0000 | 30-Sep-2021 | 0000000 000000 | 00000 |
| 000000 00000000000 | 29-Sep-2021 | 0000000 000000 | 00000 |
| 000000 (0000) | 28-Sep-2021 | 000000000000000000 | |
| 0000000 0000000000 | 06-Apr-2021 | 0000000 000000 | 00000 |
| 000000000 | 09-Mar-2021 | 000000000000000000 | |
| 0000000000 0000000 | 01-Mar-2021 | 000000000000000000 | 00000 |
| BabbleLabs | 01-Oct-2020 | Merger/Acquisition | |
| Zyomed | 19-Aug-2020 | Out of Business |
Samsung Catalyst Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialSamsung Catalyst Fund Team (31)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Christopher Chu | Managing Director | 0 | 0 | 0 | San Jose, CA |
| David Goldschmidt | Managing Director, Head of the Fund | 00 | 0 | 0 | Tel Aviv, Israel |
| Jin-Ho Ahn Ph.D | Principal | San Jose, CA | |||
| Mie Tamaki | Executive | San Jose, CA | |||
| Jeesung Lee | Head of Finance and Accounting | San Jose, CA |
Samsung Catalyst Fund Co-Investors (255)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| A&E Investments | 5 | 0 | 0 |
|
|
| Intel Capital | 0 | 0 | 0 |
|
|
| Celesta Capital | 0 | 0 | 0 |
|
|
| Robert Bosch Venture Capital | 0 | 0 | 0 |
|
|
| TransLink Capital | 0 | 0 | 0 |
|
|